Building Smart Pricing Strategies to Secure Reimbursement for Gene Therapy in Common Conditions
- Understanding how payers evaluate value when multiple therapies exist for the same disease
- Learning how coverage decisions, rebates, and clinical trade-offs impact pricing outcomes
- Exploring how to align internal teams on pricing strategy early to avoid reimbursement delays and maximize launch success